NMRA
Neumora Therapeutics, Inc.
NASDAQ: NMRA · HEALTHCARE · BIOTECHNOLOGY
$2.25
+0.00% today
Updated 2026-04-29
Market cap
$405.57M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.45
Dividend yield
—
52W range
$1 – $4
Volume
1.1M
Neumora Therapeutics, Inc. (NMRA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-121.20%
ROA
-58.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | — | — | — | — |
| 2020 | $0.00 | $-99.27M | — | — | — |
| 2021 | $0.00 | $-237.31M | — | — | — |
| 2022 | $0.00 | $-130.90M | — | — | — |
| 2023 | $0.00 | $-235.93M | — | — | — |
| 2024 | $0.00 | $-243.79M | — | — | — |
| 2025 | $0.00 | $-236.93M | — | — | — |